In 2014, 40 727 cases of pertussis were reported to TESSy by 29 EU/EEA countries. The notification rate was 9.1 cases per 100 000 population, higher than in 2013, but lower than in the epidemic year of 2012.
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
This report presents the results of an external quality assessment carried out in 2014 to test laboratories’ ability to correctly identify strains of Haemophilus influenzae.
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.
These slogans are part a toolkit which aims to support infection prevention in schools, with a focus on gastrointestinal diseases, by assisting EU/EEA countries in their communication initiatives for disease prevention in school settings.
This report describes the occurrence of invasive bacterial diseases (IBD) in Europe during 2012, based on data collected through The European Surveillance System (TESSy).
This report presents the epidemiological situation for vaccine-preventable diseases – invasive bacterial diseases (invasive Haemophilus influenzae, meningococcal and pneumococcal disease) as of 2012 and describes the statistical and epidemiological methods used.
The Annual Epidemiological Report 2014 gives an overview of the epidemiology of communicable diseases of public health significance in Europe, drawn from surveillance information on the 52 communicable diseases and health issues for which surveillance is mandatory in the European Union and European Economic Area countries.